184 related articles for article (PubMed ID: 10789369)
1. Venlafaxine and paroxetine in treatment-resistant depression.
Gregson J
Br J Psychiatry; 1999 Dec; 175():591. PubMed ID: 10789369
[No Abstract] [Full Text] [Related]
2. Drug treatment for resistant depression.
Daniels S
Br J Psychiatry; 2000 Apr; 176():398. PubMed ID: 10827893
[No Abstract] [Full Text] [Related]
3. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
[TBL] [Abstract][Full Text] [Related]
4. Drug therapy in treatment-resistant depression.
Malhi GS; Farmer AE
Br J Psychiatry; 1999 Oct; 175():390-1. PubMed ID: 10789311
[No Abstract] [Full Text] [Related]
5. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Smajkic A; Weine S; Djuric-Bijedic Z; Boskailo E; Lewis J; Pavkovic I
J Trauma Stress; 2001 Jul; 14(3):445-52. PubMed ID: 11534876
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine in somatopsychic and autopsychic depersonalization.
Preve M; Mula M; Cassano GB; Pini S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1808-9. PubMed ID: 21740948
[No Abstract] [Full Text] [Related]
7. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Denys D; van der Wee N; van Megen HJ; Westenberg HG
J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
[TBL] [Abstract][Full Text] [Related]
8. Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine.
Owens MJ; Krulewicz S; Simon JS; Sheehan DV; Thase ME; Carpenter DJ; Plott SJ; Nemeroff CB
Neuropsychopharmacology; 2008 Dec; 33(13):3201-12. PubMed ID: 18418363
[TBL] [Abstract][Full Text] [Related]
9. Serotonin reuptake inhibitors in Raynaud's phenomenon.
Jaffe IA
Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
[No Abstract] [Full Text] [Related]
10. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
11. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
Denys D; Van Nieuwerburgh F; Deforce D; Westenberg HG
J Clin Psychiatry; 2007 May; 68(5):747-53. PubMed ID: 17503984
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
Liebowitz MR; Gelenberg AJ; Munjack D
Arch Gen Psychiatry; 2005 Feb; 62(2):190-8. PubMed ID: 15699296
[TBL] [Abstract][Full Text] [Related]
13. Do venlafaxine XR and paroxetine equally influence negative and positive affect?
Dichter GS; Tomarken AJ; Freid CM; Addington S; Shelton RC
J Affect Disord; 2005 Apr; 85(3):333-9. PubMed ID: 15780704
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W;
Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199
[TBL] [Abstract][Full Text] [Related]
15. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
[TBL] [Abstract][Full Text] [Related]
16. Is Effexor more effective for depression than an SSRI?
Med Lett Drugs Ther; 2004 Feb; 46(1176):15-6. PubMed ID: 14973404
[No Abstract] [Full Text] [Related]
17. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
[TBL] [Abstract][Full Text] [Related]
18. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Brent DA
Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
[No Abstract] [Full Text] [Related]
19. [Cannabis dependence and social phobia].
Dervaux A
Encephale; 2005 Oct; 31 Pt 2():S47-8. PubMed ID: 16673708
[No Abstract] [Full Text] [Related]
20. Psychopharmacologic treatment of adolescent depression.
Lynch A; Glod CA; Fitzgerald F
Arch Psychiatr Nurs; 2001 Feb; 15(1):41-7. PubMed ID: 11172238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
